Home  >> Transactions>> Harvard Bioscience has acquired Data Sciences International

Harvard Bioscience has acquired Data Sciences International

Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, has acquire 100% of the outstanding stock of Data Sciences International, Inc. (“DSI”) for approximately $70 million (subject to adjustment for net working capital and other customary adjustments).

DSI, a St. Paul, Minnesota-based life science research company, is a recognized leader in physiologic monitoring focused on delivering preclinical products, systems, services and solutions to its customers. Its customers include pharmaceutical and biotechnology companies, as well as contract research organizations, academic labs and government researchers. For the trailing 12 months (“TTM”) ended December 31, 2017, DSI had approximately $44 million in revenue.

EC M&A acted as financial advisor to Harvard Bioscience on this transaction

Others

Dickson Data has been sold to May River Capital      Learn More >>
SPX has acquired Schonstedt Instrument Company      Learn More >>
Quantachrome Instruments has been sold to Anton Paar      Learn More >>
PIP Global has partnered with Audax Private Equity      Learn More >>
Harvard Bioscience has acquired Data Sciences International      Learn More >>
Horizon Technology has been sold to Biotage      Learn More >>
Norsk Elektro Optikk has sold NEO Monitors to Nederman      Learn More >>
AppliTek has been acquired by Hach / Danaher      Learn More >>
4titude is sold to Brooks Automation      Learn More >>
FFL Partners has acquired Bacharach      Learn More >>
Aliaxis has sold SED to Samson      Learn More >>
Spectris has sold Microscan to Omron      Learn More >>